Schedule 13G ownership disclosure
KalVista Pharmaceuticals Inc
Security class unavailable · CUSIP: 483497103
Event date: 2018-09-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,044,112
- Percent of class
- 12.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-18-056030
- Form type
- SC 13G
- Filer
- KalVista Pharmaceuticals, Inc.
- CIK
- CIK 1348911
- Filed
- Sep 10, 2018
- Reporting period
- Sep 10, 2018
- Description
- Schedule 13G beneficial ownership